Daniela Commodari
Rome, 00161, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Optimized flow cytometry assay for functional characterization of variants of uncertain significance in familial hypercholesterolemia.
Journal: Atherosclerosis
Published: December 27, 2025
The hidden burden of kidney damage in chylomicronemia syndromes.
Journal: Atherosclerosis
Published: September 09, 2025
Lomitapide-induced fatty liver is a reversible condition: Evidence from a case of familial chylomicronemia syndrome.
Journal: Journal of clinical lipidology
Published: February 13, 2025
Renal Safety Assessment of Lipid-Lowering Drugs: Between Old Certainties and New Questions.
Journal: Drugs
Published: February 09, 2025
Effect of Cholesterol-Lowering Variants in ANGPTL3 and APOB Genes on Liver Disease.
Journal: Journal of the American College of Cardiology
Published: May 09, 2024
Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events.
Journal: Journal of the American Heart Association
Published: April 23, 2021
Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: Implications for clinical diagnosis.
Journal: Journal of clinical lipidology
Published: April 20, 2021
Evolving trend in the management of heterozygous familial hypercholesterolemia in Italy: A retrospective, single center, observational study.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: January 08, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026